about
Genome-wide association studies identify four ER negative-specific breast cancer risk lociThe clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.Penetrance analysis of the PALB2 c.1592delT founder mutation.Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastasesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases.Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerRare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression networkGenetic variation in mitotic regulatory pathway genes is associated with breast tumor gradeCommon non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association ConsortiumMicroRNA related polymorphisms and breast cancer risk.Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer.Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer riskInherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.Genetic predisposition to in situ and invasive lobular carcinoma of the breast.Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association ConsortiumEvaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerCommon germline polymorphisms associated with breast cancer-specific survival.Tumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma19p13.1 is a triple-negative-specific breast cancer susceptibility locus.Common breast cancer susceptibility loci are associated with triple-negative breast cancer.Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerIdentification of novel genetic markers of breast cancer survival.11q13 is a susceptibility locus for hormone receptor positive breast cancer.Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 ExpressionFine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.The role of genetic breast cancer susceptibility variants as prognostic factors.
P50
Q24622610-09C9F874-415B-4EFB-9D71-D24084DDA229Q27824864-D590004B-9094-4E7F-A80F-9525795F10FAQ27851443-F28CCBEF-DCAB-43C0-8579-38A4EB266AD3Q28221222-FE357188-3A2C-4630-8F6C-425E85E4E648Q28584533-236303C5-47BD-464B-829F-DE2577687871Q29416989-A8DF96A9-C9CB-47AA-A33C-806AC2684740Q30374367-C24CBB76-8C74-4D90-A78D-E2836948B3BEQ31082788-54F47782-1195-4BD0-89C7-5B99B08DC0EBQ33677756-16482020-2AA1-487D-9D76-DCAFEB3341ACQ33848895-5DBB8382-B32E-4019-B65E-1BB6D17BC8A7Q33953260-63D0FC76-BD65-444A-82C5-492DADAF4D30Q34181322-D759E942-1C9B-4185-AF00-BE200B8A17B2Q34318239-E92FB42C-F150-4D09-B825-B9EE43D0B763Q34378972-B9CFA98F-A7A2-4792-974D-41EF6FF30728Q34379032-7A04B4AB-42B9-49D3-8B84-D34D60F7527BQ34497352-D3E7F4C6-8B8F-4A23-8081-A4D8104A61A3Q34695260-417F443F-FC81-472A-B7C8-EBD965E571E8Q34903062-3FD20F9C-0F17-43D9-A5C7-047D1946C609Q35022847-1B283583-85A1-4609-8BD3-DC26C560F418Q35064451-3F1B01D5-D1DC-4413-953C-663A221C9438Q35102646-94319E70-9464-453D-821E-28C81239184AQ35104068-340A7AF7-8737-453C-A289-C8666F1F9BE6Q35151684-DADF8713-B89F-4E83-9AA8-54787739815DQ35155449-A2683C01-177E-45B2-A3BB-8FE943980064Q35179897-A36C28A9-E7A4-4752-8D49-AB1F6B4A1442Q35524465-B7F50667-0E7C-43E6-AC1E-BD929523A031Q35532898-72D140BE-6D05-4B58-9A17-906B7FABD316Q35653910-F45CC6A9-C479-43CD-9E28-DA2652B0758EQ35755874-CC805286-CCA1-4983-8BFA-EDD410B11E56Q35794653-F5740A4B-84F9-4BEC-A615-7C2D0A20ACF0Q35798941-FC4BB6F4-97F3-4C24-983A-F07137B2CCF0Q35871567-34C5F464-F5D0-49E6-B762-8345AA36F983Q35891162-02B463CA-6D46-42AC-8B8B-81D1F7907A35Q35906993-0981FEA7-11CE-4C1C-9C36-CCE2B3F393ECQ35996692-173EF1EA-7C00-4BA9-A5CB-9DC0F7599E33Q36014067-482E8B9E-39D2-46DE-BFBF-A00E2F2F89C2Q36016386-EBDB328A-F17E-4E82-868D-CE96F92E588EQ36066735-90D61C04-F0CD-4A93-856D-CD3547E46B36Q36111237-7D0900C4-78BB-4DBC-8F25-9484339D777AQ36142060-10242821-7246-4F3A-A0BC-262C1606EB1B
P50
description
onderzoeker
@nl
name
Arja Jukkola-Vuorinen
@ast
Arja Jukkola-Vuorinen
@en
Arja Jukkola-Vuorinen
@es
Arja Jukkola-Vuorinen
@nl
Arja Jukkola-Vuorinen
@sl
type
label
Arja Jukkola-Vuorinen
@ast
Arja Jukkola-Vuorinen
@en
Arja Jukkola-Vuorinen
@es
Arja Jukkola-Vuorinen
@nl
Arja Jukkola-Vuorinen
@sl
prefLabel
Arja Jukkola-Vuorinen
@ast
Arja Jukkola-Vuorinen
@en
Arja Jukkola-Vuorinen
@es
Arja Jukkola-Vuorinen
@nl
Arja Jukkola-Vuorinen
@sl
P106
P21
P31
P569
2000-01-01T00:00:00Z